Mechanism and therapeutic reversal of immune suppression in cancer

被引：34

作者：

Herber, Donna L. ^{[1
]}

Nagaraj, Srinivas ^{[1
]}

Djeu, Julie Y. ^{[1
]}

Gabrilovich, Dmitry I. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

来源：

CANCER RESEARCH | 2007年 / 67卷 / 11期

关键词：

D O I：

10.1158/0008-5472.CAN-07-0897

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5067 / 5069

页数：3

共 14 条

[1] Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
Antonia, SJ
Mirza, N
Fricke, I
Chiappori, A
Thompson, P
Williams, N
Bepler, G
Simon, G
Janssen, W
Lee, JH
Menander, K
Chada, S
Gabrilovich, DI
[J]. CLINICAL CANCER RESEARCH, 2006, 12 (03) : 878 - 887
[2] Cancer vaccines: Between the idea and the reality
Finn, OJ
[J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (08) : 630 - 641
[3] Mechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D
[J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (12) : 941 - 952
[4] The role of the transcription factor Foxp3 in the development of regulatory T cells
Kim, Jeong M.
Rudensky, Alexander
[J]. IMMUNOLOGICAL REVIEWS, 2006, 212 : 86 - 98
[5] Checkpoint blockade in cancer immunotherapy
Korman, AJ
Peggs, KS
Allison, JP
[J]. ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY, 2006, 90 : 297 - 339
[6] Immunotherapy for pancreatic cancer - Science driving clinical progress
Laheru, D
Jaffee, EM
[J]. NATURE REVIEWS CANCER, 2005, 5 (06) : 459 - 467
[7] Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation
Munn, DH
[J]. CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (02) : 220 - 225
[8] T cell dysfunction in cancer:: Role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress
Rodríguez, PC
Ochoa, AC
[J]. SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) : 66 - 72
[9] Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
Serafini, P
Borrello, I
Bronte, V
[J]. SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) : 53 - 65
[10] Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression
Sinha, P
Clements, VK
Miller, S
Ostrand-Rosenberg, S
[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (11) : 1137 - 1142

← 1 2 →